جاهز للتشغيل
جاهز للتشغيل
Johnson & Johnson has offered up to $5.5 billion to settle tens of thousands of lawsuits claiming its talcum-based baby powder causes ovarian cancer. The company denies the allegations and has changed its formula, but the settlement aims to resolve a long-standing legal challenge. J&J announced in 2022 it would cease sales of talc-based baby powder globally, transitioning to a cornstarch-based product.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading